Official Title
the Effect of HFNC Treatment on Mortality and Length of ICU Stay in Patient With COVID-19 Pneumonia
Brief Summary

coronavirus disease 2019 related pneumonia is causing acute respiratory failure and this is the most common reason for ICU admission. We have several different way for respiratory support. HFNC is one of the new technics for oxygen support. Our main purpose to observe the effect of HFNC on coronavirus disease 2019 patients' ICU stay and mortality.

Detailed Description

In the first group (group H), the data of patients undergoing HFNC treatment, and in group II
(Group K), the data of patients who received COT with a reservoir mask were included.

In HFNC support, the current air temperature is 31-37 degrees, the flow rate is 30-60 lt /
min, and the FiO2 value is targeted so that saturation is 93% and above. Initially,
continuous treatment was applied intermittently after the partial oxygen pressure / fraction
of inspired oxygen(fio2) ratio exceeded 250 and clinical well-being occurred.

In patients in Group K, fingertip saturation was targeted as 93% and above, and a COT was
applied with a reservoir mask with a flow rate of 6-15 l / min.

The flow rate was calculated using the formula of FiO2 (%) = 21 + 4 * (liters / min) in
patients undergoing COT. Noninvasive mechanical ventilation was applied to patients who could
not be provided with adequate clinical and laboratory well-being in both groups (partial
oxygen pressure / fraction of inspired oxygen ratio below 150) and invasive mechanical
ventilation if this was insufficient.

Completed
Coronavirus Infection
Pneumonia, Viral
Acute Respiratory Failure

Device: high flow nasal cannula device

device is supplying oxygen with heated and humidified air in a high flow rate

Eligibility Criteria

Inclusion Criteria:

- We include the patient with acute respiratory failure related coronavirus disease 2019
(diagnosed with polymerase Chain Reaction), older than 18 year and supported by High
Flow Nasal cannulae or conventional oxygen treatment(COT).

Exclusion Criteria:

- Patients with primary pulmonary disease, Glasgow Coma scale≤ 12 , respiratory acidosis
in the first blood gases(ph≤ 7,2 - pCO2≥50) will exclude.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Turkey
Locations

Sisli Etfal Research and Training Hospital
Istanbul, Turkey

ayse su cinar, Study Chair

Sisli Hamidiye Etfal Training and Research Hospital
NCT Number
Keywords
high flow nasal cannula (HFNC)
conventional oxygen treatment (COT)
MeSH Terms
Pneumonia
Coronavirus Infections
Pneumonia, Viral
Respiratory Insufficiency